Translational Research

Research in Hepatology & Liver Disease

Dr. Pascal's research focuses on hepatocellular carcinoma (liver cancer) — particularly risk stratification, early detection biomarkers, and therapeutic response prediction in Chinese patient populations. His work bridges clinical hepatology with translational molecular research.

View Publications →Collaborate
Research Focus Areas

Areas of Investigation

Hepatocellular Carcinoma (HCC)

Risk stratification, recurrence prediction, and biomarker identification in HBV-related and NASH-related liver cancer.

Liver Disease Progression

Non-alcoholic fatty liver disease (NAFLD) to cirrhosis transition mechanisms and clinical staging validation.

Therapeutic Response Biomarkers

Identifying molecular markers that predict response to systemic therapy in advanced hepatocellular carcinoma.

China-Africa Health Outcomes

Comparative epidemiology and clinical outcome differences for African patients treated within the Chinese healthcare system.

Publications

Research Publications

Figure from Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation
PublishedHepatology International2025
Predictive value of neutrophil-to-lymphocyte ratio in recurrent HCC after repeat hepatectomy or salvage liver transplantation
Kwangwari P, et al.
doi:10.1007/s12072-025-10786-7
  • ArchitectureBiomarker response model
  • DesignAdvanced HCC therapeutic-response analysis
  • ResultsInflammation-response signal placeholder
Figure from Acute carbon monoxide poisoning with low saturation of carboxyhaemoglobin: a forensic retrospective study in Shanghai, China
PublishedScientific Reports2021
Acute carbon monoxide poisoning with low saturation of carboxyhaemoglobin: a forensic retrospective study in Shanghai, China
Kwangwari P, et al.
doi:10.1038/s41598-021-97436-8
  • ArchitectureRecurrence-risk stratification
  • DesignRepeat hepatectomy vs. salvage liver transplant cohort
  • ResultsNLR as a predictor of post-recurrence outcomes
PublishedScientific Reports2021
Prognostic Value of Preoperative Inflammatory Markers in Predicting Recurrence After Hepatic Resection for HBV-Related Hepatocellular Carcinoma
Kwangwari P, et al.
  • ArchitectureForensic case-series analysis
  • DesignRetrospective autopsy review, Shanghai region
  • ResultsLow-COHb saturation cases re-characterised
Experience

Clinical & Research Experience

Translational R&D Researcher — Hepatobiliary Oncology & Transplant Immunology
Fudan University Zhongshan Hospital
Sep 2023 – Present
Research
Research Associate — Post-Transplant Immunopathology & GVHD
Fudan University Zhongshan Hospital
Aug 2024 – Sep 2025
Research
Clinical Research Associate Intern — CAR-T Cell Therapy
Shanghai Origin Cell Therapeutics
Jul 2021 – Aug 2021
Clinical
Undergraduate Research Analyst — Forensic Epidemiology & Biomarker Study
Fudan University Forensic Science
2021
Research
Technical Skills

Skills & Competencies

In Vivo Models
  • —Murine hepatic ischemia-reperfusion
  • —Intrasplenic tumor injection
  • —Retro-orbital venous sampling
  • —Liver perfusion
  • —Microsurgical dissection
Cell & Molecular
  • —THP-1 macrophage polarization
  • —ELISA
  • —Western blot
  • —PCR
  • —TUNEL apoptosis
  • —CCK-8 viability
  • —Transwell migration / invasion
Genomics & Omics
  • —RNA-sequencing interpretation
  • —Mass spectrometry proteomics
  • —IHC / IF markers
  • —CRISPR/Cas9 (conceptual design)
Data & Analysis
  • —RStudio · GraphPad Prism · SPSS
  • —Biomarker study design
  • —Retrospective cohort analysis
  • —EMR dataset management
  • —GCP compliance
  • —Scientific writing

Interested in Research Collaboration?

Open to joint research, co-authorship, and data-sharing opportunities in hepatology and liver disease.

Propose Collaboration →